Office of Research Assurances

Biosafety

Responsibilities of a Researcher / Extension and other WSU personnel


  1. Understand Biosafety practices and principles(November 7th, 2006)
  2. Perform risk assessments for the plant activities involving potentially biohazardous material
    • For more information on Risk Assessments see Section 3 of the BSL-2 manual template and Supplemental Resources F for additional risk assessment resources, or see Section II Biological Risk Assessment section of BMBL edition 5.
  3. Develop Biosafety Manuals
    • Biosafety Manuals are required for all plant research activities involving recombinant DNA. Click here for access to the BSL-1 manual template.
    • b. All plant activities at BSL2-P click here for access to the BSL-2 manual template.
  4. Train staff/students in biosafety practices
    • Click here to access WSU biosafety Website trainings currently available.
  5. All plant activities (even those classified as exempt based on current NIH Guidelines) that involve the use of recombinant DNA molecules must be submitted via a BAF form, reviewed and approved by the Institutional Biosafety Committee (IBC) prior to beginning the work.
  6. All plant activities that involve potentially biohazardous material must be submitted via a BAF form, reviewed and approved by the IBC prior to beginning work.
  7. All planting of deregulated items in WSU fields or by WSU employees in any fields must be registered via a DFPRF (Deregulated Field Planting Registration Form).
  8. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-052.html

    "Investigators and institutions are reminded that they must adhere to the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) when they perform research that is conducted at or sponsored by an entity receiving any NIH support for recombinant DNA research. Therefore, even privately funded projects employing recombinant DNA must adhere to the NIH Guidelines if they are being carried out at, or funded by, an organization that has any NIH contracts, grants, or other support for this kind of research. Adherence to the NIH Guidelines is mandatory and important because they stipulate biosafety and containment measures for recombinant DNA research. Furthermore, they delineate critical ethical principles and outline key safety reporting requirements for human gene transfer research."

  9. Obtain permits and permissions prior to commencement of work. Submit copies of permits with the BAF submission.
  10. Report accidents, adverse events, and unplanned events (including natural) to the IBC.
Office of Research Assurances, P.O. Box 643143, Neil Room 428, Washington State University, Pullman WA 99164-3143
Phone: 509-335-7195, Fax: 509-335-6410, ibc@wsu.edu